Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B

European Radiology

Volumn 24, Issue 1, 2014, Pages 70-78

  Venkatesh, Sudhakar Kundapur ^a,b   Wang, Gang ^a   Lim, Seng Gee ^a   Wee, Aileen ^a  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b MAYO CLINIC   (United States)

Author keywords

Chronic hepatitis B; Cirrhosis; Fibrosis; Magnetic resonance elastography; Serum markers

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; PROTHROMBIN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC HEPATITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOGRAPH; ELASTOGRAPHY; FEMALE; HEPATITIS B; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; LIVER FIBROSIS; MAGNETIC RESONANCE ELASTOGRAPHY; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; STAGING; THROMBOCYTE COUNT;

ADULT; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; ELASTICITY; ELASTICITY IMAGING TECHNIQUES; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 84890440193     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-013-2978-8     Document Type: Article

References (56)

1. Liver EAFTSOT (2012) EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 57:167-185
2. Fattovich G (2003) Natural history and prognosis of hepatitis B. Semin Liver Dis 23:47-58
3. McMahon BJ (2004) The natural history of chronic hepatitis B virus infection. Semin Liver Dis 24:17-21
4. Hadziyannis SJ, Papatheodoridis GV (2006) Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatment. Semin Liver Dis 26:130-141
5. Fattovich G, Olivari N, Pasino M, D'Onofrio M, Martone E, Donato F (2008) Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years. Gut 57:84-90
6. Fattovich G, Stroffolini T, Zagni I, Donato F (2004) Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127:S35-S50
7. Bosch FX, Ribes J, Cléries R, Díaz M (2005) Epidemiology of hepatocellular carcinoma. Clin Liver Dis 9:191-211
8. Lok AS, McMahon BJ (2009) Chronic hepatitis B: update 2009. Hepatology 50:661-662
9. Dienstag JL, Goldin RD, Heathcote EJ et al (2003) Histological outcome during long-term lamivudine therapy. Gastroenterology 124:105-117
10. Marcellin P, Chang TT, Lim SG et al (2008) Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigenpositive chronic hepatitis B. Hepatology 48:750-758
11. Chang TT, Liaw YF,Wu SS et al (2010) Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology 52:886-893
12. Liver EAFTSOT (2009) EASL clinical practice guidelines: management of chronic hepatitis B. J Hepatol 50:227-242
13. Castéra L, Nègre I, Samii K, Buffet C (1999) Pain experienced during percutaneous liver biopsy. Hepatology 30:1529-1530
14. Castera L (2011) Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease. Best Pract Res Clin Gastroenterol 25:291-303
15. Piccinino F, Sagnelli E, Pasquale G, Giusti G (1986) Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 2:165-173
16. Bravo AA, Sheth SG, Chopra S (2001) Liver biopsy. N Engl J Med 344:495-500
17. Cadranel JF, Rufat P, Degos F (2000) Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 32:477-481
18. Regev A, Berho M, Jeffers L et al (2002) Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97:2614-2618
19. Maharaj B, Maharaj R, LearyWet al (1986) Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1:523-525
20. Wai CT, Greenson JK, Fontana RJ et al (2003) A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38:518-526
21. Castera L (2012) Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology 142:1293-1302, e1294
22. Rockey DC, Bissell DM (2006) Noninvasive measures of liver fibrosis. Hepatology 43:S113-S120
23. Halfon P, Bacq Y, De Muret A et al (2007) Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C. J Hepatol 46:395-402
24. Chan HL,Wong GL, Choi PC et al (2009) Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepat 16:36-44
25. WongGL,WongVW, Choi PC et al (2008) Assessment of fibrosis by transient elastography compared with liver biopsy and morphometry in chronic liver diseases. Clin Gastroenterol Hepatol 6:1027-1035
26. Castéra L, Foucher J, Bernard PH et al (2010) Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 51:828-835
27. Friedrich-Rust M, Nierhoff J, Lupsor M et al (2012) Performance of acoustic radiation force impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepat 19:e212-e219
28. Sporea I, Sirli R, Popescu A, Danilǎ M (2010) Acoustic radiation force impulse (ARFI)-a new modality for the evaluation of liver fibrosis. Med Ultrason 12:26-31
29. Yin M, Talwalkar JA, Glaser KJ et al (2007) Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 5:1207-1213, e1202
30. Huwart L, Sempoux C, Salameh N et al (2007) Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology 245:458-466
31. Huwart L, Sempoux C, Vicaut E et al (2008) Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 135:32-40
32. Rustogi R, Horowitz J, Harmath C et al (2012) Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis. J Magn Reson Imaging 35:1356-1364
33. Wang Y, Ganger DR, Levitsky J et al (2011) Assessment of chronic hepatitis and fibrosis: comparison ofMR elastography and diffusion-weighted imaging. AJR Am J Roentgenol 196:553-561
34. Godfrey EM, Patterson AJ, Priest AN et al (2012) A comparison of MRelastography and 31PMR spectroscopy with histological staging of liver fibrosis. Eur Radiol 22:2790-2797
35. Wang QB, Zhu H, Liu HL, Zhang B (2012) Performance ofmagnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: a meta-analysis. Hepatology 56:239-247
36. Kim BH, Lee JM, Lee YJ et al (2011) MR elastography for noninvasive assessment of hepatic fibrosis: experience from a tertiary center in Asia. J Magn Reson Imaging 34:1110-1116
37. Ichikawa S,Motosugi U, Ichikawa Tet al (2012)Magnetic resonance elastography for staging liver fibrosis in chronic hepatitis C. Magn Reson Med Sci 11:291-297
38. Chen J, Talwalkar JA, Yin M, Glaser KJ, Sanderson SO, Ehman RL (2011) Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 259:749-756
39. Vizzotto L, Vertemati M, Gambacorta M, Sabatella G, Goffredi M, Minola E (2005) Computerized morphometry in liver cirrhosis: histological and immunohistochemical properties. In: Liver cirrhosis: new research. Nova Science, New York, p 97-112
40. YanoM, Kumada H, KageMet al (1996) The long-term pathological evolution of chronic hepatitis C. Hepatology 23:1334-1340
41. Kage M, Shimamatu K, Nakashima E, Kojiro M, Inoue O, Yano M (1997) Long-term evolution of fibrosis from chronic hepatitis to cirrhosis in patients with hepatitis C: morphometric analysis of repeated biopsies. Hepatology 25:1028-1031
42. Marcellin P, ZiolM, Bedossa P et al (2009) Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 29:242-247
43. Vizzotto L, Vertemati M, Gambacorta M, Sabatella G, Spina V, Minola E (2002) Analysis of histological and immunohistochemical patterns of the liver in posthepatitic and alcoholic cirrhosis by computerized morphometry. Mod Pathol 15:798-806
44. Bensamoun SF, Leclerc GE, Debernard L et al (2013) Cutoff values for alcoholic liver fibrosis using magnetic resonance elastography technique. Alcohol Clin Exp Res 37:811-817
45. Kim D, Kim WR, Talwalkar JA, Kim HJ, Ehman RL (2013) Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography. Radiology. doi:10.1148/radiol. 13121193
46. Bohte AE, van Dussen L, Akkerman EM et al (2013) Liver fibrosis in type I Gaucher disease: magnetic resonance imaging, transient elastography and parameters of iron storage. PLoS One 8:e57507
47. Venkatesh SK, Yin M, Ehman RL (2013) Magnetic resonance elastography of liver: technique, analysis, and clinical applications. J Magn Res Imaging 37:544-555
48. Bedossa P, Poynard T (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24:289-293
49. Motosugi U, Ichikawa T, Sano K et al (2010) Magnetic resonance elastography of the liver: preliminary results and estimation of inter-rater reliability. Jpn J Radiol 28:623-627
50. Hines CDG, Bley TA, Lindstrom MJ, Reeder SB (2010) Repeatability of magnetic resonance elastography for quantification of hepatic stiffness. J Magn Res Imaging 31:725-731
51. Shire NJ, Yin M, Chen J et al (2011) Test-retest repeatability of MR elastography for noninvasive liver fibrosis assessment in hepatitis C. J Magn Reson Imaging 34:947-955
52. Fraquelli M, Rigamonti C, Casazza G et al (2011) Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C. J Hepatol 54:621-628
53. Myers RP, Crotty P, Pomier-Layrargues G, Ma M, Urbanski SJ, ElkashabM(2010) Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy. Liver Int 30:1471-1480
54. Poynard T, Halfon P, Castera L et al (2007) Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin Chem 53:1615-1622
55. Asbach P, Klatt D, Hamhaber U et al (2008) Assessment of liver viscoelasticity using multifrequency MR elastography. Magn Reson Med 60:373-379
56. Mariappan YK, Venkatesh SK, Glaser KJ, McGee KP, Ehman RL (2013) MR elastography of liver with iron overload: development, evaluation and preliminary clinical experience with improved spin echo and spin echo EPI sequences. Proceedings of the 21st annual meeting of ISMRM, Salt Lake City, 2012 (abstract 985)